Target intelligence / Profile preview

NADP-dependent isopropanol dehydrogenase

Molecular classification
Enzyme, Oxidoreductase, Alcohol dehydrogenase family
01

Overview

NADP-dependent isopropanol dehydrogenase is an enzyme that catalyzes the reversible oxidation of isopropanol (propan-2-ol) to acetone, using NADP+ as an electron acceptor and generating NADPH and a proton[1][5][6]. It primarily acts on medium-chain secondary alcohols with low activity for primary alcohols; it can also reduce aldehydes and 2-ketones to the corresponding secondary alcohols[1][5]. The enzyme belongs to the oxidoreductase family, specifically the alcohol dehydrogenases acting on the CH-OH group of donors with NADP+ as cofactor. It is of particular interest in industrial biotechnology for biocatalysis and metabolic engineering aimed at renewable production of acetone, isopropanol, and the regeneration of cofactors (NADPH) in bioprocesses[6][1]. Human therapeutic targeting of this enzyme is not established, and its principal applications are in microbial or enzymatic biotransformations. It is also identified by EC number 1.1.1.80 and has been studied in organisms such as Thermoanaerobacter brockii and engineered strains of bacteria[1][5][6].

Other names
isopropanol dehydrogenase (NADP+)EC 1.1.1.80propan-2-ol:NADP+ oxidoreductase1.1.1.80
02

Mechanism of action

Catalyzes reversible oxidation-reduction of isopropanol and acetone via NADP+ reduction to NADPH, typically in microorganisms or engineered organisms[1][5][6]

03

Biological functions

Catalysis of the oxidation of isopropanol (propan-2-ol) to acetone using NADP+ as a cofactorReduction of aldehydes and 2-ketones to produce secondary alcoholsParticipation in propanoate metabolism
04

Disease associations

Other (no well-established direct links to classic disease areas such as cancer or infection, primarily used in metabolic engineering and industrial biotechnology)[5][6]
05

Safety considerations

No major human therapeutic applications are reported; not known as a drug target in human therapy, so safety concerns are not well-characterizedIn industrial or engineered microbial use, potential safety considerations are related to handling of acetone, isopropanol, and engineered strains
06

Interacting drugs

2-Butanol (investigational, unknown pharmacological action)[1]

1 more in the full profile.

Beyond the preview

Go deeper on NADP-dependent isopropanol dehydrogenase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADP-dependent isopropanol dehydrogenase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call